Finally, the disease progression of NF-2 contributed to the OS equilibrium between the two groups, in spite of the benign biological behavior of schwannomas (Table 1); (3) longer follow-up time in the present series (86.4 months) compared to previous studies (Table 2). This evidence concerns the gene NF2 and schwannoma.